<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03178747</url>
  </required_header>
  <id_info>
    <org_study_id>674/59</org_study_id>
    <nct_id>NCT03178747</nct_id>
  </id_info>
  <brief_title>Tzanck Smear With Methylene Blue Stain for Herpes</brief_title>
  <official_title>A Comparative Study of Tzanck Smear With Methylene Blue Versus Giemsa Stain to Diagnose Herpes Simplex, Herpes Zoster and Varicella Zoster Skin Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Dermatological Society of Thailand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the sensitivity of Tzanck smear with methylene blue stain versus traditional
      Giemsa stain in patients with herpes infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A smear from the lesional skin of the patients suspected having Herpes simplex, Herpes zoster
      and Varicella zoster skin infections will be collected (in a clinical routine setting). The
      specimen will be stained with methylene blue in addition to the Giemsa stain. Polymerase
      chain reaction study for herpes antigen will be performed in some of the specimens. The
      sensitivity, specificity, positive predictive value and negative predictive value will be
      calculated from the results of the study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 7, 2017</start_date>
  <completion_date type="Anticipated">March 6, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 7, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity</measure>
    <time_frame>24 weeks</time_frame>
    <description>Positive results from staining compared with number of cases</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Factors that contribute the results from Methylene blue staining</measure>
    <time_frame>24 weeks</time_frame>
    <description>Subgroup analysis which included age, sex, clinical morphology, distribution, duration of lesion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Herpes Simplex</condition>
  <condition>Herpes Zoster</condition>
  <condition>Varicella Zoster</condition>
  <arm_group>
    <arm_group_label>Case</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients who clinically diagnosed as herpes simplex, herpes zoster or varicella zoster skin infection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Negative control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Patients who develops vesicular lesion but not typically considered as herpesviral skin infection, such as acute eczema, Paederus dermatitis</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Methylene blue</intervention_name>
    <description>working solution methylene blue</description>
    <arm_group_label>Case</arm_group_label>
    <arm_group_label>Negative control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Giemsa stain</intervention_name>
    <description>working solution Giemsa stain (Wolbach's modification)</description>
    <arm_group_label>Case</arm_group_label>
    <arm_group_label>Negative control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with clinically suspected of having herpes simplex, herpes zoster, varicella
             zoster skin infections.

          -  Those who have vesicular skin lesion such as acute eczema, Paederus dermatitis.

          -  Those are well cooperative.

          -  Age &gt; 18 years old.

        Exclusion Criteria:

          -  Those who are not willing to have specimen from skin lesions to be collected.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pawinee Rerknimitr, MD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chulalongkorn University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pawinee Rerknimitr, MD, MSc</last_name>
    <phone>+6622564253</phone>
    <email>pawinee.r@chula.ac.th</email>
  </overall_contact>
  <location>
    <facility>
      <name>Division of Dermatology, Faculty of Medicine, Chulalongkorn University</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pawinee Rerknimitr, MD, MSc</last_name>
      <phone>+6622564253</phone>
      <email>pawinee.r@chula.ac.th</email>
    </contact>
    <investigator>
      <last_name>Kittipong Wantavornprasert, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pokrath Hansasuta, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2017</study_first_submitted>
  <study_first_submitted_qc>June 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 7, 2017</study_first_posted>
  <last_update_submitted>August 3, 2017</last_update_submitted>
  <last_update_submitted_qc>August 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chulalongkorn University</investigator_affiliation>
    <investigator_full_name>Pawinee Rerknimitr</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>Methylene blue</keyword>
  <keyword>Giemsa</keyword>
  <keyword>Tzanck smear</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Herpes Zoster</mesh_term>
    <mesh_term>Herpes Simplex</mesh_term>
    <mesh_term>Chickenpox</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylene Blue</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

